Curasight plans directed share sale of at least DKK 18 million

  • Curasight launched an accelerated bookbuild for a directed share issue of at least DKK 18 million, offered only to qualified investors.
  • Proceeds earmarked to bolster working capital, funding uTRACE and uTREAT development through H1 2027.
  • Subscription price set via bookbuilding, due to end before trading starts on Spotlight on June 23, 2026.
  • Fenja Capital loan renegotiation planned; total outstanding about DKK 35.7 million, with maturity targeted to extend to June 30, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curasight A/S published the original content used to generate this news brief via Cision (Ref. ID: 202606221243BITN____UKPR__EN_20260622-BIT-0450-0) on June 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.